Sen. Grassley Seeks Info On Prodisc Researchers

Law360, New York (February 27, 2008, 12:00 AM EST) -- Concerned over reports of impropriety, a prominent Republican senator is reportedly demanding answers from the U.S. Food and Drug Administration and the maker of Prodisc over rumors that some doctors involved in the clinical research of the synthetic spinal disk stood to gain financially from the medication's success.

Sen. Charles E. Grassley (R-Iowa), the ranking member of the Senate Finance Committee, shipped a letter off to the FDA and Synthes on Wednesday, asking for information about what regulators knew about the clinical investigators prior to Prodisc's...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.